| answer text |
<p>Antimicrobial resistance (AMR) is a major global health threat, and tackling it
is a UK priority. DFID, alongside the Department of Health and Social Care, provides
support to developing countries' health and hygiene services, which also supports
tackling antimicrobial resistance.</p><p> </p><p>DFID support includes work to prevent
infection and, in turn, reduce the need for antimicrobials. For example, through DFID’s
support to GAVI, the Vaccine Alliance, the UK will help immunise 300 million children
between 2016 and 2020.</p><p> </p><p>DFID also supports the prompt diagnosis and treatment
of disease and the development of new drugs and diagnostic tools to treat resistant
infection. DFID investment in the Global Fund to Fight AIDS, TB and Malaria contributed
towards treating 102,000 people for drug-resistant tuberculosis in 2017. The Department
of Health and Social Care’s £265 million Fleming Fund also supports low and middle-income
countries to improve surveillance and laboratory capacity for addressing AMR.</p><p>
</p><p>Since 2015 DFID has also supported 40 million people to gain access to clean
water and sanitation, and DFID also supports water, sanitation and hygiene in healthcare
facilities, both of which are important for preventing infection.</p>
|
|
